UTAH MEDICAL PRODUCTS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (Deprecated 2011-01-31)
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (Deprecated 2011-01-31) of 55.29 thousand shares for the 12-month period ending 2013-12-31, per its 10-K filed 2014-03-12.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriod · last filed 2014-03-12
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period (deprecated 2011-01-31) for fiscal 2013 was 55.29K shares, a 32.89% decline from fiscal 2012.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period (deprecated 2011-01-31) for fiscal 2012 was 82.39K shares, a 288.25% increase from fiscal 2011.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period (deprecated 2011-01-31) for fiscal 2011 was 21.22K shares, a 22.07% decline from fiscal 2010.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, exercises in period (deprecated 2011-01-31) for fiscal 2010 was 27.23K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (Deprecated 2011-01-31) 12 month |
|---|---|
| 2013-12-31 | 55.29K shares 10-K · filed 2014-03-12 |
| 2012-12-31 | 82.39K shares 10-K · filed 2014-03-12 |
| 2011-12-31 | 21.22K shares 10-K · filed 2014-03-12 |
| 2010-12-31 | 27.23K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |